PTPN1 and cancer: Mechanistically, PTPN1 promotes glioma progression through activation of MAPK/Erk and PI3K/AKT pathways as well as IL-13-mediated adhesion, migration and invasion of IL13Rα2-expressing cancer cells (93, 95).